Smith+Nephew Welcomes Encouraging Start to 2022

Smith+Nephew reported 1Q22 orthopedic sales of $916.2 million, +2% vs. 1Q21.

New CEO Deepak Nath is less than a month into his tenure and deferred any substantive remarks until the company's second-half earnings. However, he did commit to Smith+Nephew's strategic goals of strengthening the supply chain, accelerating growth while maintaining...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us